This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Thyrocare Technologies to Acquire Polo Labs' Diagnostic and Pathological Services MT
Thyrocare Technologies Limited entered into business transfer agreement to acquire Diagnostic and pathological services business of Polo Labs Private Limited from Polo Labs Private Limited for INR 42.6 million. CI
Transcript : Thyrocare Technologies Limited, Q4 2024 Earnings Call, May 14, 2024
Thyrocare Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Thyrocare Technologies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Thyrocare Technologies Limited Proposes Final Dividend for the Financial Year 2023-24 CI
India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand RE
Thyrocare Technologies Limited Announces Resignation of Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer CI
Thyrocare Technologies Completes Acquisition of Think Health; Shares Jump 6% MT
Thyrocare Technologies Limited completed the acquisition of Think Health Diagnostic Private Limited. CI
Thyrocare Technologies Limited Pays and Settles Due Cess Amount Including Interest and Penalty Amount to Navi Mumbai Municipal Corporation, Cess Department CI
Thyrocare Technologies Appoints Chief Commercial Officer MT
Thyrocare Technologies Limited Appoints Nitin Chugh as Chief Commercial Officer CI
Thyrocare Technologies Posts Gains in Fiscal Q3 Consolidated Profit MT
Transcript : Thyrocare Technologies Limited, Q3 2024 Earnings Call, Feb 01, 2024
Thyrocare Technologies Limited Appoints Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer CI
Thyrocare Technologies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests RE
Thyrocare Technologies to Acquire 100% Stake in Think Health Diagnostic MT
Thyrocare Technologies Limited agreed to acquire Think Health Diagnostic Private Limited for INR 3.2 million. CI
Transcript : Thyrocare Technologies Limited, Q2 2024 Earnings Call, Oct 31, 2023
Indian shares set to open lower with HDFC, Fed decision in focus RE
Thyrocare Technologies Forms Joint Venture in Tanzania MT
Thyrocare Technologies Limited Enter into A Subscription Agreement At Tanzania with Kastipharm Limited and Other Individuals for Setting Up A Joint Venture Company CI
Thyrocare Technologies Names CFO MT
Chart Thyrocare Technologies Limited
More charts
Thyrocare Technologies Limited is an India-based healthcare services provider in diagnostic area. The Company has diagnostic chains that conduct a range of medical diagnostic tests and profiles of tests that is focused on early detection and management of health disorders and diseases. The Company's segments include Diagnostic Testing Services, Imaging Services and Others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services includes diagnostic and imaging services, selling of radio-pharmaceutical, selling of consumables for reporting. The Others segment include the sale of testing equipment and consumables, and selling of glucometer and glucostrips under the brand, Sugarscan. The Company has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, a medical cyclotron facility and PET-CT facilities across India.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
644.1 INR
Average target price
740 INR
Spread / Average Target
+14.89%
Consensus
  1. Stock Market
  2. Equities
  3. THYROCARE Stock
  4. News Thyrocare Technologies Limited
  5. Thyrocare Technologies Forms Joint Venture in Tanzania